| CASE REPORT |
|
| Year : 2022 | Volume
: 26
| Issue : 2 | Page : 96-98 |
|
|
Saudi adolescent present with new-onset vitiligo post-COVID-19 vaccination: Case report
Abdullah A Alnaim1, Amnah N Al-Mulhim2, Mohammed M Al-Momen1, Lenah Y Shaikh2
1 College of Medicine, King Faisal University, Hofuf, Saudi Arabia
2 Department of Medicine, Section of Dermatology, King Fahad Specialist Hospital, Dammam, Saudi Arabia
Correspondence Address:
Dr. Abdullah A Alnaim
King Faisal University, Hofuf
Saudi Arabia
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/jdds.jdds_35_22
|
|
|
Coronavirus disease of 2019 (COVID-19) is a relatively new pandemic; the first reported case was in late 2019, and the first vaccine was given in December 2020. To this date, multiple side effects have been reported with COVID-19 vaccines. Nonetheless, autoimmune (AI) diseases with the COVID-19 vaccine have rarely been associated. We described herein a case of sudden onset of vitiligo occurring after the first dose of the COVID-19 vaccine. To date, there are less than 10 reported cases of vitiligo post-COVID-19 vaccine. This report aims to recognize AI disease presentation with vaccines, specifically COVID-19.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
